A Gene Deletion Vaccine is a vaccine developed without the ability to replicate by deleting important genes.These substances are very harmless because they cannot be released into the environment.Another benefit of live vaccines is that they can often be delivered via the mucosal route, which is a natural route of infection, thereby inducing mucosal immunity through systemic immunity.By increasing mucosal immunity, disease progression can be halted at the onset of infection.

The global Gene-Deleted Vaccines market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Gene-Deleted Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gene-Deleted Vaccines.

Report Scope

The Gene-Deleted Vaccines market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Gene-Deleted Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Gene-Deleted Vaccines companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Gene-Deleted Vaccines Market Report

Report Metric	Details
Report Name	Gene-Deleted Vaccines Market
CAGR	5%
Segment by Type	Single Gene Deleted Vaccine Double Gene Deleted Vaccine
Segment by Application	Veterinary Hospitals Veterinary Clinics Animal Care Centers Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Virbac SA, Merck Animal Health, Zoetis Inc, Boehringer Ingelheim GmbH, Ceva, Bayer, Biogenesis-Bago, Indian Immunologicals Ltd, Heska Corporation
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Gene-Deleted Vaccines companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Gene-Deleted Vaccines Market report?

Ans: The main players in the Gene-Deleted Vaccines Market are Virbac SA, Merck Animal Health, Zoetis Inc, Boehringer Ingelheim GmbH, Ceva, Bayer, Biogenesis-Bago, Indian Immunologicals Ltd, Heska Corporation

What are the Application segmentation covered in the Gene-Deleted Vaccines Market report?

Ans: The Applications covered in the Gene-Deleted Vaccines Market report are Veterinary Hospitals, Veterinary Clinics, Animal Care Centers, Others

What are the Type segmentation covered in the Gene-Deleted Vaccines Market report?

Ans: The Types covered in the Gene-Deleted Vaccines Market report are Single Gene Deleted Vaccine, Double Gene Deleted Vaccine

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Gene-Deleted Vaccines Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Single Gene Deleted Vaccine

1.2.3 Double Gene Deleted Vaccine

1.3 Market by Application

1.3.1 Global Gene-Deleted Vaccines Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Veterinary Hospitals

1.3.3 Veterinary Clinics

1.3.4 Animal Care Centers

1.3.5 Others

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Gene-Deleted Vaccines Market Perspective (2019-2030)

2.2 Gene-Deleted Vaccines Growth Trends by Region

2.2.1 Global Gene-Deleted Vaccines Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Gene-Deleted Vaccines Historic Market Size by Region (2019-2024)

2.2.3 Gene-Deleted Vaccines Forecasted Market Size by Region (2025-2030)

2.3 Gene-Deleted Vaccines Market Dynamics

2.3.1 Gene-Deleted Vaccines Industry Trends

2.3.2 Gene-Deleted Vaccines Market Drivers

2.3.3 Gene-Deleted Vaccines Market Challenges

2.3.4 Gene-Deleted Vaccines Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Gene-Deleted Vaccines Players by Revenue

3.1.1 Global Top Gene-Deleted Vaccines Players by Revenue (2019-2024)

3.1.2 Global Gene-Deleted Vaccines Revenue Market Share by Players (2019-2024)

3.2 Global Gene-Deleted Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Gene-Deleted Vaccines Revenue

3.4 Global Gene-Deleted Vaccines Market Concentration Ratio

3.4.1 Global Gene-Deleted Vaccines Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Gene-Deleted Vaccines Revenue in 2023

3.5 Gene-Deleted Vaccines Key Players Head office and Area Served

3.6 Key Players Gene-Deleted Vaccines Product Solution and Service

3.7 Date of Enter into Gene-Deleted Vaccines Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Gene-Deleted Vaccines Breakdown Data by Type

4.1 Global Gene-Deleted Vaccines Historic Market Size by Type (2019-2024)

4.2 Global Gene-Deleted Vaccines Forecasted Market Size by Type (2025-2030)

5 Gene-Deleted Vaccines Breakdown Data by Application

5.1 Global Gene-Deleted Vaccines Historic Market Size by Application (2019-2024)

5.2 Global Gene-Deleted Vaccines Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Gene-Deleted Vaccines Market Size (2019-2030)

6.2 North America Gene-Deleted Vaccines Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Gene-Deleted Vaccines Market Size by Country (2019-2024)

6.4 North America Gene-Deleted Vaccines Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Gene-Deleted Vaccines Market Size (2019-2030)

7.2 Europe Gene-Deleted Vaccines Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Gene-Deleted Vaccines Market Size by Country (2019-2024)

7.4 Europe Gene-Deleted Vaccines Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Gene-Deleted Vaccines Market Size (2019-2030)

8.2 Asia-Pacific Gene-Deleted Vaccines Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Gene-Deleted Vaccines Market Size by Region (2019-2024)

8.4 Asia-Pacific Gene-Deleted Vaccines Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Gene-Deleted Vaccines Market Size (2019-2030)

9.2 Latin America Gene-Deleted Vaccines Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Gene-Deleted Vaccines Market Size by Country (2019-2024)

9.4 Latin America Gene-Deleted Vaccines Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Gene-Deleted Vaccines Market Size (2019-2030)

10.2 Middle East & Africa Gene-Deleted Vaccines Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Gene-Deleted Vaccines Market Size by Country (2019-2024)

10.4 Middle East & Africa Gene-Deleted Vaccines Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Virbac SA

11.1.1 Virbac SA Company Detail

11.1.2 Virbac SA Business Overview

11.1.3 Virbac SA Gene-Deleted Vaccines Introduction

11.1.4 Virbac SA Revenue in Gene-Deleted Vaccines Business (2019-2024)

11.1.5 Virbac SA Recent Development

11.2 Merck Animal Health

11.2.1 Merck Animal Health Company Detail

11.2.2 Merck Animal Health Business Overview

11.2.3 Merck Animal Health Gene-Deleted Vaccines Introduction

11.2.4 Merck Animal Health Revenue in Gene-Deleted Vaccines Business (2019-2024)

11.2.5 Merck Animal Health Recent Development

11.3 Zoetis Inc

11.3.1 Zoetis Inc Company Detail

11.3.2 Zoetis Inc Business Overview

11.3.3 Zoetis Inc Gene-Deleted Vaccines Introduction

11.3.4 Zoetis Inc Revenue in Gene-Deleted Vaccines Business (2019-2024)

11.3.5 Zoetis Inc Recent Development

11.4 Boehringer Ingelheim GmbH

11.4.1 Boehringer Ingelheim GmbH Company Detail

11.4.2 Boehringer Ingelheim GmbH Business Overview

11.4.3 Boehringer Ingelheim GmbH Gene-Deleted Vaccines Introduction

11.4.4 Boehringer Ingelheim GmbH Revenue in Gene-Deleted Vaccines Business (2019-2024)

11.4.5 Boehringer Ingelheim GmbH Recent Development

11.5 Ceva

11.5.1 Ceva Company Detail

11.5.2 Ceva Business Overview

11.5.3 Ceva Gene-Deleted Vaccines Introduction

11.5.4 Ceva Revenue in Gene-Deleted Vaccines Business (2019-2024)

11.5.5 Ceva Recent Development

11.6 Bayer

11.6.1 Bayer Company Detail

11.6.2 Bayer Business Overview

11.6.3 Bayer Gene-Deleted Vaccines Introduction

11.6.4 Bayer Revenue in Gene-Deleted Vaccines Business (2019-2024)

11.6.5 Bayer Recent Development

11.7 Biogenesis-Bago

11.7.1 Biogenesis-Bago Company Detail

11.7.2 Biogenesis-Bago Business Overview

11.7.3 Biogenesis-Bago Gene-Deleted Vaccines Introduction

11.7.4 Biogenesis-Bago Revenue in Gene-Deleted Vaccines Business (2019-2024)

11.7.5 Biogenesis-Bago Recent Development

11.8 Indian Immunologicals Ltd

11.8.1 Indian Immunologicals Ltd Company Detail

11.8.2 Indian Immunologicals Ltd Business Overview

11.8.3 Indian Immunologicals Ltd Gene-Deleted Vaccines Introduction

11.8.4 Indian Immunologicals Ltd Revenue in Gene-Deleted Vaccines Business (2019-2024)

11.8.5 Indian Immunologicals Ltd Recent Development

11.9 Heska Corporation

11.9.1 Heska Corporation Company Detail

11.9.2 Heska Corporation Business Overview

11.9.3 Heska Corporation Gene-Deleted Vaccines Introduction

11.9.4 Heska Corporation Revenue in Gene-Deleted Vaccines Business (2019-2024)

11.9.5 Heska Corporation Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Virbac SA

Merck Animal Health

Zoetis Inc

Boehringer Ingelheim GmbH

Ceva

Bayer

Biogenesis Bago

Indian Immunologicals Ltd

Heska Corporation

List of Tables

Table 1. Global Gene-Deleted Vaccines Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Single Gene Deleted Vaccine

Table 3. Key Players of Double Gene Deleted Vaccine

Table 4. Global Gene-Deleted Vaccines Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 5. Global Gene-Deleted Vaccines Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Gene-Deleted Vaccines Market Size by Region (2019-2024) & (US$ Million)

Table 7. Global Gene-Deleted Vaccines Market Share by Region (2019-2024)

Table 8. Global Gene-Deleted Vaccines Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 9. Global Gene-Deleted Vaccines Market Share by Region (2025-2030)

Table 10. Gene-Deleted Vaccines Market Trends

Table 11. Gene-Deleted Vaccines Market Drivers

Table 12. Gene-Deleted Vaccines Market Challenges

Table 13. Gene-Deleted Vaccines Market Restraints

Table 14. Global Gene-Deleted Vaccines Revenue by Players (2019-2024) & (US$ Million)

Table 15. Global Gene-Deleted Vaccines Market Share by Players (2019-2024)

Table 16. Global Top Gene-Deleted Vaccines Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene-Deleted Vaccines as of 2023)

Table 17. Ranking of Global Top Gene-Deleted Vaccines Companies by Revenue (US$ Million) in 2023

Table 18. Global 5 Largest Players Market Share by Gene-Deleted Vaccines Revenue (CR5 and HHI) & (2019-2024)

Table 19. Key Players Headquarters and Area Served

Table 20. Key Players Gene-Deleted Vaccines Product Solution and Service

Table 21. Date of Enter into Gene-Deleted Vaccines Market

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Gene-Deleted Vaccines Market Size by Type (2019-2024) & (US$ Million)

Table 24. Global Gene-Deleted Vaccines Revenue Market Share by Type (2019-2024)

Table 25. Global Gene-Deleted Vaccines Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 26. Global Gene-Deleted Vaccines Revenue Market Share by Type (2025-2030)

Table 27. Global Gene-Deleted Vaccines Market Size by Application (2019-2024) & (US$ Million)

Table 28. Global Gene-Deleted Vaccines Revenue Market Share by Application (2019-2024)

Table 29. Global Gene-Deleted Vaccines Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 30. Global Gene-Deleted Vaccines Revenue Market Share by Application (2025-2030)

Table 31. North America Gene-Deleted Vaccines Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 32. North America Gene-Deleted Vaccines Market Size by Country (2019-2024) & (US$ Million)

Table 33. North America Gene-Deleted Vaccines Market Size by Country (2025-2030) & (US$ Million)

Table 34. Europe Gene-Deleted Vaccines Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 35. Europe Gene-Deleted Vaccines Market Size by Country (2019-2024) & (US$ Million)

Table 36. Europe Gene-Deleted Vaccines Market Size by Country (2025-2030) & (US$ Million)

Table 37. Asia-Pacific Gene-Deleted Vaccines Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 38. Asia-Pacific Gene-Deleted Vaccines Market Size by Region (2019-2024) & (US$ Million)

Table 39. Asia-Pacific Gene-Deleted Vaccines Market Size by Region (2025-2030) & (US$ Million)

Table 40. Latin America Gene-Deleted Vaccines Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 41. Latin America Gene-Deleted Vaccines Market Size by Country (2019-2024) & (US$ Million)

Table 42. Latin America Gene-Deleted Vaccines Market Size by Country (2025-2030) & (US$ Million)

Table 43. Middle East & Africa Gene-Deleted Vaccines Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 44. Middle East & Africa Gene-Deleted Vaccines Market Size by Country (2019-2024) & (US$ Million)

Table 45. Middle East & Africa Gene-Deleted Vaccines Market Size by Country (2025-2030) & (US$ Million)

Table 46. Virbac SA Company Detail

Table 47. Virbac SA Business Overview

Table 48. Virbac SA Gene-Deleted Vaccines Product

Table 49. Virbac SA Revenue in Gene-Deleted Vaccines Business (2019-2024) & (US$ Million)

Table 50. Virbac SA Recent Development

Table 51. Merck Animal Health Company Detail

Table 52. Merck Animal Health Business Overview

Table 53. Merck Animal Health Gene-Deleted Vaccines Product

Table 54. Merck Animal Health Revenue in Gene-Deleted Vaccines Business (2019-2024) & (US$ Million)

Table 55. Merck Animal Health Recent Development

Table 56. Zoetis Inc Company Detail

Table 57. Zoetis Inc Business Overview

Table 58. Zoetis Inc Gene-Deleted Vaccines Product

Table 59. Zoetis Inc Revenue in Gene-Deleted Vaccines Business (2019-2024) & (US$ Million)

Table 60. Zoetis Inc Recent Development

Table 61. Boehringer Ingelheim GmbH Company Detail

Table 62. Boehringer Ingelheim GmbH Business Overview

Table 63. Boehringer Ingelheim GmbH Gene-Deleted Vaccines Product

Table 64. Boehringer Ingelheim GmbH Revenue in Gene-Deleted Vaccines Business (2019-2024) & (US$ Million)

Table 65. Boehringer Ingelheim GmbH Recent Development

Table 66. Ceva Company Detail

Table 67. Ceva Business Overview

Table 68. Ceva Gene-Deleted Vaccines Product

Table 69. Ceva Revenue in Gene-Deleted Vaccines Business (2019-2024) & (US$ Million)

Table 70. Ceva Recent Development

Table 71. Bayer Company Detail

Table 72. Bayer Business Overview

Table 73. Bayer Gene-Deleted Vaccines Product

Table 74. Bayer Revenue in Gene-Deleted Vaccines Business (2019-2024) & (US$ Million)

Table 75. Bayer Recent Development

Table 76. Biogenesis-Bago Company Detail

Table 77. Biogenesis-Bago Business Overview

Table 78. Biogenesis-Bago Gene-Deleted Vaccines Product

Table 79. Biogenesis-Bago Revenue in Gene-Deleted Vaccines Business (2019-2024) & (US$ Million)

Table 80. Biogenesis-Bago Recent Development

Table 81. Indian Immunologicals Ltd Company Detail

Table 82. Indian Immunologicals Ltd Business Overview

Table 83. Indian Immunologicals Ltd Gene-Deleted Vaccines Product

Table 84. Indian Immunologicals Ltd Revenue in Gene-Deleted Vaccines Business (2019-2024) & (US$ Million)

Table 85. Indian Immunologicals Ltd Recent Development

Table 86. Heska Corporation Company Detail

Table 87. Heska Corporation Business Overview

Table 88. Heska Corporation Gene-Deleted Vaccines Product

Table 89. Heska Corporation Revenue in Gene-Deleted Vaccines Business (2019-2024) & (US$ Million)

Table 90. Heska Corporation Recent Development

Table 91. Research Programs/Design for This Report

Table 92. Key Data Information from Secondary Sources

Table 93. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Gene-Deleted Vaccines Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Gene-Deleted Vaccines Market Share by Type: 2023 VS 2030

Figure 3. Single Gene Deleted Vaccine Features

Figure 4. Double Gene Deleted Vaccine Features

Figure 5. Global Gene-Deleted Vaccines Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 6. Global Gene-Deleted Vaccines Market Share by Application: 2023 VS 2030

Figure 7. Veterinary Hospitals Case Studies

Figure 8. Veterinary Clinics Case Studies

Figure 9. Animal Care Centers Case Studies

Figure 10. Others Case Studies

Figure 11. Gene-Deleted Vaccines Report Years Considered

Figure 12. Global Gene-Deleted Vaccines Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 13. Global Gene-Deleted Vaccines Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 14. Global Gene-Deleted Vaccines Market Share by Region: 2023 VS 2030

Figure 15. Global Gene-Deleted Vaccines Market Share by Players in 2023

Figure 16. Global Top Gene-Deleted Vaccines Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene-Deleted Vaccines as of 2023)

Figure 17. The Top 10 and 5 Players Market Share by Gene-Deleted Vaccines Revenue in 2023

Figure 18. North America Gene-Deleted Vaccines Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 19. North America Gene-Deleted Vaccines Market Share by Country (2019-2030)

Figure 20. United States Gene-Deleted Vaccines Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. Canada Gene-Deleted Vaccines Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Europe Gene-Deleted Vaccines Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Europe Gene-Deleted Vaccines Market Share by Country (2019-2030)

Figure 24. Germany Gene-Deleted Vaccines Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. France Gene-Deleted Vaccines Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. U.K. Gene-Deleted Vaccines Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. Italy Gene-Deleted Vaccines Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Russia Gene-Deleted Vaccines Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Nordic Countries Gene-Deleted Vaccines Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Asia-Pacific Gene-Deleted Vaccines Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Asia-Pacific Gene-Deleted Vaccines Market Share by Region (2019-2030)

Figure 32. China Gene-Deleted Vaccines Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Japan Gene-Deleted Vaccines Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. South Korea Gene-Deleted Vaccines Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Southeast Asia Gene-Deleted Vaccines Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. India Gene-Deleted Vaccines Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Australia Gene-Deleted Vaccines Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Latin America Gene-Deleted Vaccines Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Latin America Gene-Deleted Vaccines Market Share by Country (2019-2030)

Figure 40. Mexico Gene-Deleted Vaccines Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Brazil Gene-Deleted Vaccines Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Middle East & Africa Gene-Deleted Vaccines Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Middle East & Africa Gene-Deleted Vaccines Market Share by Country (2019-2030)

Figure 44. Turkey Gene-Deleted Vaccines Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Saudi Arabia Gene-Deleted Vaccines Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Virbac SA Revenue Growth Rate in Gene-Deleted Vaccines Business (2019-2024)

Figure 47. Merck Animal Health Revenue Growth Rate in Gene-Deleted Vaccines Business (2019-2024)

Figure 48. Zoetis Inc Revenue Growth Rate in Gene-Deleted Vaccines Business (2019-2024)

Figure 49. Boehringer Ingelheim GmbH Revenue Growth Rate in Gene-Deleted Vaccines Business (2019-2024)

Figure 50. Ceva Revenue Growth Rate in Gene-Deleted Vaccines Business (2019-2024)

Figure 51. Bayer Revenue Growth Rate in Gene-Deleted Vaccines Business (2019-2024)

Figure 52. Biogenesis-Bago Revenue Growth Rate in Gene-Deleted Vaccines Business (2019-2024)

Figure 53. Indian Immunologicals Ltd Revenue Growth Rate in Gene-Deleted Vaccines Business (2019-2024)

Figure 54. Heska Corporation Revenue Growth Rate in Gene-Deleted Vaccines Business (2019-2024)

Figure 55. Bottom-up and Top-down Approaches for This Report

Figure 56. Data Triangulation

Figure 57. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions